Compare Medpace Holdings Inc (MEDP) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Medpace Holdings Inc trades at $532.89 (market cap $15.08B), while Direxion Daily TSLA Bull 2X Shares trades at $11.33. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| MEDP | TSLL | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $23.03 |
52-Week Low | $308.88 | $10.29 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
TSLL is trading at $10.72, down 5.84% with a bearish technical outlook. The stock faces selling pressure with moving averages indicating a downtrend and key resistance at $12. Recent news highlights upcoming Tesla earnings as a potential catalyst, though financial ratios remain unavailable for fundamental assessment.
The stock's outlook is cautious due to technical weakness and lack of current financial data. Investment opportunity hinges on Tesla's upcoming earnings report, while risks include sustained bearish momentum and dependency on Tesla's performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
